HealthKois launches $300 million fund to invest in high-impact startups

HealthKois, India’s premier healthcare transformation fund, has launched with a target corpus of $300 million, and an additional green shoe option of $100 million.

The fund has been established by the key leadership team behind HealthQuad—Charles Janssen (Managing Partner), Ajay Mahipal (Partner), and Dr. Pinak Shrikhande (Partner). As a successor fund to HealthQuad, HealthKois will invest in technology-enabled, scalable, and high-impact startups.

Over the next four years, the firm will invest between $7 million to $25 million per company in early growth-stage businesses operating across healthtech, life sciences, medtech, healthcare delivery and climate health. The fund is focused on supporting startups that offer robust operational scalability, demonstrable clinical outcomes, and sustainable infrastructure solutions. 

“HealthKois will back technology-led and innovative healthcare companies that address critical gaps in accessibility, affordability, and quality of care. Our goal is to transform care delivery by enabling early-growth ventures that bring real-world impact,” said Charles Janssen, Managing Partner, HealthKois.

“With access to over 75% proprietary deal flow, we’re well-positioned to leverage our deep networks and operational expertise to deliver both superior financial returns and societal outcomes.” 

HealthKois said it adopts a founder-first, hands-on approach. The firm will leverage a global network across Asia and Europe to supports its portfolio with strategic guidance, go-to-market planning, organizational design, and governance. 

“HealthKois represents our deep belief that meaningful change in healthcare can only be achieved by scaling enterprises that blend purpose with performance,”,” said Ajay Mahipal, Partner, HealthKois.

“At HealthKois, we’re not just capital providers, we are long-term collaborators with founders, bringing strategic direction, global networks, and deep sector knowledge to help unlock their full potential. We invest in ventures that revolutionize healthcare delivery while also strengthening infrastructure resilience in India and other LMIC markets.” 

“Our experience has taught us that true innovation in healthcare is born out of empathy, evidence, and execution,” said Dr. Pinak Shrikhande, Partner, HealthKois.

“We look for companies that go beyond intent to deliver real clinical and operational impact. Transformation doesn’t happen in silos, it requires a blend of clinical insight, practical know-how, and the conviction to back bold ideas.”